Ardelyx, Inc.

ARDX
$6.27 (+ $0.18 + 2.96%)
Last updated: 2026-05-21 03:39 UTC
ARDX Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS0396971071
CUSIP039697107
Market Price6.27
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.23
Market Cap$1.4B
Book Value0.64
Price to Book9.134
Beta0.55
52w High6.78
52w Low3.21
Next Earnings DateN/A

Ardelyx, Inc. trades under ticker ARDX on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US0396971071, CUSIP 039697107. Also searched as Ardelyx.

Related researchARDX stock priceARDX share price039697107Ardelyx stockArdelyx share price
About the Company
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Price History